Skip to content

Savara SVRA Other Income (Expense)

Other Income (Expense) at other companies

XER
Xeris Biopharma Holdings, Inc.XERS
-$5.68M+7.3%
Innoviva, Inc. logo
Innoviva, Inc.INVA
-$366K+63.3%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$3.01M+221%
ANI Pharmaceuticals logo
ANI PharmaceuticalsANIP
-$651K-429%
TRV
Trevi Therapeutics, Inc.TRVI
$1.7M+51.9%
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
$11.27M+62.0%

Other financials

Income statement

See full
Revenue-
Operating income-$39.0M-37.1%
Net income-$37.3M-40.0%
EPS (diluted)-$0.15-25.0%

Balance sheet

See full
Cash & equivalents$38.8M+98.4%
Total debt$30.1M+1.8%
Total equity$176.0M+19.1%
Total assets$221.6M+17.1%

Cash flow

See full
Operating cash flow-$33.0M-21.5%
CapEx$54.0K+1,700%
Free cash flow-$33.1M-21.7%

Valuation

See full
Market cap$1.19B+134%
Enterprise value$1.19B+127%
P/S4,648.7×

Profitability

See full
Operating margin-19,183.3%
Net margin-19,305.1%
FCF margin-15,518.7%

Returns & leverage

See full
Return on equity-80%+4.7pp
Debt / equity0.2×0.0×
Current ratio13.5×-1.4×

Where this comes from

Reported directly by Savara in its filing.

Tagged under the XBRL concept us-gaap:OtherNonoperatingIncomeExpense.

The official record: Savara’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Savara's other income (expense).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Savara's other income (expense)?
Savara (SVRA) reported other income (expense) of $1.71M in Q1 2026.
How has Savara's other income (expense) changed year-over-year?
Savara's other income (expense) decreased by 5.0% year-over-year, from $1.8M to $1.71M.
What is the long-term trend for Savara's other income (expense)?
Over 4 years (2021 to 2025), Savara's other income (expense) has grown at a 32.3% compound annual growth rate (CAGR), from -$1.54M to $4.71M.
What does other income (expense) mean?
Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.